Investments
NSSF: Still room to increase PE investments
China's National Council for Social Security Fund (NSSF) has the capacity to boost its commitments to private equity considerably, having put only 2.2% of its capital into the asset class, according to Wang Zhongmin, the fund's vice chairman.
Mitsui Global Investment backs Belgian pharma firm
Mitsui Global Investment, a subsidiary of Japan's Mitsui & Co, has participated in a Series B round worth EUR23.6 million ($31.4 million) for Belgian pharmaceutical company Promethera Biosciences.
Lazard-backed 2XU acquires Sports Multiplied
Australian technical sports apparel brand 2XU, which is backed by Lazard Private Equity, has acquired its US-based distributor Sports Multiplied, in a move to expand across the globe.
Looking forward, looking back
The first quarter of 2012 will soon be over. The Asian private equity industry seems to be humming along at a steady pace, although there hasn’t been anything particularly dramatic so far. Deal-making has been efficient and routine rather than startling,...
Vision Knight Capital invests in Silver Lake-backed Allyes
Allyes Group, a Chinese online media service provider, has received a strategic investment from Vision Knight Capital, the private equity firm set up by former Alibaba CEO David Wei. It is the largest single investment by Vision Knight since its inception...
Baring PE India to complete fully deploy Fund III by mid-2013
Baring Private Equity Partners India plans to complete its current investment cycle by mid-2013. The PE firm has raised more than $770 million across three funds and the most recent vehicle - which closed in 2008 at $560 million - is the only one not...
Private equity heads into China’s hinterlands
From resources to consumer plays, western China is rich in opportunities for private equity investors, but an unwillingness or inability to build strong local teams is holding back progress
Lunar Capital gets 60% stake in Chinese beverage brand
Lunar Capital Management has acquired a majority interest in Sichuan Zhiqiang Group, an integrated food manufacturer located in western China, in a deal worth up to $50 million.
Abraaj Capital to complete more deals in Asia
Abraaj Capital is set to complete more deals in Asia in the next few months. The Middle East private equity firm will look for deals largely in India and pursue possible acquisitions in natural resource companies in Indonesia.
Chinese PE players continue to go west
Chinese private equity investors are moving west to tap opportunities in the country’s underdeveloped inland provinces, according to a recent study conducted by global management consulting firm Bain & Company and the European Union Chamber of Commerce...
Advantage Partners may extend investment deadline
Advantage Partners may extend the June deadline for investment from its $2.6 billion buyout fund due to limited dealflow. The buyout firm will make a decision by the end of April.
Macro: Indonesia’s growth story
Expanding by more than 6% per year, the Indonesian economy is already one of the best performers in Asia. But analysts say it has the capacity to match growth rates in China and India, reforms permitting
Indonesia investment: Uncharted territory
For all its attractions, Indonesia remains a difficult – and expensive – market for foreign private equity firms. Identifying value rests on building up local knowledge and expertise
Fosun plans new fund to finance overseas investments
Fosun International, China's largest privately-owned investment conglomerate, is going to raise another dollar-denominated private equity fund this year to finance new acquisitions. The company will seek investment opportunities in Europe and Japan.
Craftsman Automation seeks $20m from PE investors
Coimbatore-based auto component manufacturer Craftsman Automation is in talks with private equity investors to raise a corpus worth between INR850 million and INRI billion.
Morgan Stanley invests $90m in Mumbai project
Morgan Stanley Real Estate Investment (MSREI), the real estate fund of global investment bank Morgan Stanley, has invested in a $90 million Indian realty project owned by Sheth Developers.
CITIC Capital in $1.6bn Cinda deal
CITIC Capital, alongside Standard Chartered and UBS, has reportedly been approved to be a strategic investor in China Cinda Asset Management Co., which will also receive a capital injection from China’s national pension fund. The total investment will...
India Venture Advisors backs drugs manufacturer
India Venture Advisors, the healthcare and life sciences-focused private equity fund founded by Ajay Piramal and former State Bank of India (SBI) chairman A K Purwar, has invested INR700 million ($13.8 million) in drug manufacturer Vardhman Chemtech.
Hudson Clean Energy makes China debut
Asia Pacific's waste-to-energy market is projected to grow threefold in the next five years and China is central to this trend. Cleantech consultancy Pike Research expects the country’s revenues to hit $3.7 billion by the end of the period, up from...
PAG Asia bets $250m on Chinese pharmco
China is entering a new era, with its new model for growth powered by technology and innovation rather than a focus on cheap manufacturing. Biotechnology, as one of the seven “strategic emerging industries” in the 12th Five-Year plan, is experiencing...
Chinese PE players eye overseas deals
Demand for outbound investments is growing , but there are still hurdles that must be overcome.
Indian VC’s social imperative
Social venture capital funds have sprung up in India under the notion that they can support marginalized communities and achieve financial returns. Time will tell if this is possible.
Ascent invests $10m in Indian online grocery store
Ascent capital has committed $10 million to a series A funding round for Bigbasket.com, an Indian online grocery store. The transaction is said to be the largest ever Series A round for an e-commerce company as well as the first institutional investment...
EQT Partners invests in China Healthcare
EQT Partners has teamed up with the founder of China Healthcare and put in a cash offer to take the Singapore-listed company private. The deal values China Healthcare at S$80.4 million ($64 million).